These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38550588)

  • 1. Macrophages in acne vulgaris: mediating phagocytosis, inflammation, scar formation, and therapeutic implications.
    Feng Y; Li J; Mo X; Ju Q
    Front Immunol; 2024; 15():1355455. PubMed ID: 38550588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of bacteriophage φPaP11-13 attenuates rat
    Liu Y; Zhen N; Liao D; Niu J; Liu R; Li Z; Lei Z; Yang Z
    Microbiol Spectr; 2024 Feb; 12(2):e0283823. PubMed ID: 38197658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway.
    Mias C; Mengeaud V; Bessou-Touya S; Duplan H
    J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():3-11. PubMed ID: 36729400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluating treatment targets in acne vulgaris: adapting to a new understanding of pathophysiology.
    Kircik LH
    J Drugs Dermatol; 2014 Jun; 13(6):s57-60. PubMed ID: 24918572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIG1459: A novel phytyl-cysteine derived TLR2 modulator with in vitro and clinical anti-acne activity.
    Fernández JR; Webb C; Rouzard K; Healy J; Tamura M; Voronkov M; Huber KL; Stock JB; Stock M; Gordon JS; Pérez E
    Exp Dermatol; 2018 Sep; 27(9):993-999. PubMed ID: 29797368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From pathogenesis of acne vulgaris to anti-acne agents.
    Cong TX; Hao D; Wen X; Li XH; He G; Jiang X
    Arch Dermatol Res; 2019 Jul; 311(5):337-349. PubMed ID: 30859308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutibacterium acnes: Much ado about maybe nothing much.
    van Steensel MAM; Goh BC
    Exp Dermatol; 2021 Oct; 30(10):1471-1476. PubMed ID: 34009698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphene Attenuates
    Hwang HJ; Kim JE; Lee KW
    J Microbiol Biotechnol; 2022 Nov; 32(11):1390-1395. PubMed ID: 36437519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes.
    Keshari S; Kumar M; Balasubramaniam A; Chang TW; Tong Y; Huang CM
    Expert Rev Vaccines; 2019 May; 18(5):433-437. PubMed ID: 30920859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee Venom and Its Major Component Melittin Attenuated
    Gu H; An HJ; Gwon MG; Bae S; Leem J; Lee SJ; Han SM; Zouboulis CC; Park KK
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic acne scar: a process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor-β1 signalling.
    Moon J; Yoon JY; Yang JH; Kwon HH; Min S; Suh DH
    Br J Dermatol; 2019 Dec; 181(6):1226-1237. PubMed ID: 30822364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A narrative review of research progress on the role of
    Zhu W; Wang HL; Bu XL; Zhang JB; Lu YG
    Ann Transl Med; 2022 Jun; 10(11):645. PubMed ID: 35813328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
    J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
    Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of different cell types and inflammation in early acne vulgaris.
    Huang L; Yang S; Yu X; Fang F; Zhu L; Wang L; Zhang X; Yang C; Qian Q; Zhu T
    Front Immunol; 2024; 15():1275269. PubMed ID: 38357543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increasing importance of the gut microbiome in acne vulgaris.
    Siddiqui R; Makhlouf Z; Khan NA
    Folia Microbiol (Praha); 2022 Dec; 67(6):825-835. PubMed ID: 35711021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic and transcriptomic investigation of acne vulgaris microcystic and papular lesions: Insights in the understanding of its pathophysiology.
    Quanico J; Gimeno JP; Nadal-Wollbold F; Casas C; Alvarez-Georges S; Redoulès D; Schmitt AM; Fournier I; Salzet M
    Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):652-663. PubMed ID: 27789243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 macrophages induced by human lipids drive inflammation in acne lesions.
    Do TH; Ma F; Andrade PR; Teles R; de Andrade Silva BJ; Hu C; Espinoza A; Hsu JE; Cho CS; Kim M; Xi J; Xing X; Plazyo O; Tsoi LC; Cheng C; Kim J; Bryson BD; O'Neill AM; Colonna M; Gudjonsson JE; Klechevsky E; Lee JH; Gallo RL; Bloom BR; Pellegrini M; Modlin RL
    Sci Immunol; 2022 Jul; 7(73):eabo2787. PubMed ID: 35867799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.